Investigating how mDia2 affects the formation of red blood cells
The roles of mDia2 in membrane remodeling and organelle clearance during reticulocyte formation
This study is looking at how red blood cells develop and what happens when a certain protein is missing, which could help us understand blood-related diseases better and improve ways to make red blood cells for transfusions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10819576 on NIH RePORTER |
What this research studies
This research focuses on understanding the final stages of red blood cell formation, particularly how cells called reticulocytes mature from erythroblasts. It examines the role of a protein called mDia2 in the process of enucleation, where the nucleus is expelled from the cell, and how this affects the motility and structure of reticulocytes. By using a specific mouse model lacking mDia2, the researchers aim to uncover the mechanisms that regulate organelle clearance and cell shape during this critical phase of erythropoiesis. The findings could provide insights into red blood cell-related diseases and improve strategies for generating red blood cells for transfusions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to red blood cell formation, such as various types of anemia.
Not a fit: Patients with non-hematological conditions or those not affected by red blood cell production issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatments for anemia and improved methods for producing red blood cells for transfusions.
How similar studies have performed: While the specific role of mDia2 in reticulocyte formation is being explored, similar research has shown promise in understanding erythropoiesis and related disorders.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Ji, Peng — Northwestern University at Chicago
- Study coordinator: Ji, Peng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.